Rooted in biotechnology, Biocogent utilises proven expertise in advanced research and development, engineering, manufacturing, and testing to provide our customers with innovative, scientifically-relevant ingredients. As a result, Biocogent products are distinguished by science-backed efficacy and substantiated claims.
As leading scientific research continues to demonstrate the fundamental roles that the microbiome plays in skin wellness and beauty, Biocogent delivers new categories of microbiome-modulating active ingredients to the skin care industry. Utilising innovative biotechnologies, Biocogent develops products that restore and maintain a balanced skin microbiome to address common skin concerns, including DermaPhage® and Pleiotanical® products.
DermaPhage® products feature highly specific bacteriophages to safely and effectively balance the skin microbiome. DermaPhage® CA is a microbiome-selective approach clinically shown to manage blemish-prone skin by targeting the microbial culprit, Cutibacterium acnes.
Produced using proprietary Pleiotanical® extraction methods, Grandiciin® is a bioactive, whole-cell Epimedium sagittatum extract that delivers potent microbiome-modulatory effects to soothe, smooth, and improve blemished skin.